Passage Bio
PASG
PASG
58 hedge funds and large institutions have $34M invested in Passage Bio in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 67 → 58 (-9)
34% less capital invested
Capital invested by funds: $51.5M → $34M (-$17.5M)
64% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 14
Holders
58
Holding in Top 10
3
Calls
$2K
Puts
$1K
Top Buyers
| 1 | +$287K | |
| 2 | +$224K | |
| 3 | +$49.5K | |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
+$43.1K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$22.4K |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$331K | |
| 3 | -$253K | |
| 4 |
Renaissance Technologies
New York
|
-$217K |
| 5 |
B
Bailard
Foster City,
California
|
-$217K |